Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Open House Pharmaceutical Discounts On The Active Ingredient Enalapril, Atc C09aa02 2025-11-19
United Kingdom Non Clinical Staffing 2 2025-11-19
Germany Open-house Drug Discount Contracts In Accordance With Section 130a (8c) Sgb V For The Kv Region Mecklenburg-western Pomerania 2025-11-19
Germany Open-house Drug Discount Contracts In Accordance With Section 130a (8c) Sgb V For The Kv Region Brandenburg 2025-11-19
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Carglum Acid, Atc A16aa05 For The Time 01.07.2025 30.06.2027 (plus Extension Option 1x12 Months) 2025-11-19
Germany Completion Not Excl. Pharmaceutical Discount Club. According To § 130a Para. 8 Sgb V In The Way Of An Open House Model To The Active Ingredient Ustekinumab (atccode According To Who 2025-11-19
Germany Open-house-drug Discount Contracts In Accordance With Section 130a (8c) Sgb V For The Kv-region Berlin 2025-11-19
Germany Open House Pharmaceutical Dact Treaties To The Active Ingredient Leuprorelin, Atc L02ae02, H01ca04 2025-11-19
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Lenalidomide, Atc L04ax04 For The Time 01.07.2025 30.06.2027 (plus Extension Option 1x12 Months), Medicines 2025-11-19
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Glatirameracetate (exclusively Dosage Form), Atc L03ax13 For The Time 01.07.25 30.06.27, Medicines 2025-11-19
Whats app